EVP, Head of R&D · Zymeworks Inc. · Zymeworks Inc. — Restricted Stock Unit
Side
M
Value
—
Shares
37.0K
Price
—
Executed
Oct 9, 2026
Disclosed
Oct 9, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Oct 9 executedOct 9, 2026 disclosed
ZYME · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 100.0% of prior position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Schayowitz Adam filed this Form 4 reporting a option exercise of ZYME on Oct 9, 2026. It became public on Oct 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Head of R&D
Schayowitz Adamcik:0002127119
Issuer
Zymeworks Inc.cik:0001937653
Revision history · 0
No field has changed since this record was first ingested.
